JD

Jahangir Dastgir Shaikh

Active Director Director DIN 10527131
DIN 10527131 First appointment Feb 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Jahangir Dastgir Shaikh

Data last updated:

Jahangir Dastgir Shaikh is a Director at Absien Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10527131
Primary Designation Director
Industry Pharma
First Appointment 28 Feb 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Feb 20242024Active

Board colleagues of Jahangir Dastgir Shaikh

NameDINCompanyDesignation
Amar Maulasab Shaikh10773545Absien Pharmaceuticals Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Absien Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jahangir Dastgir Shaikh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jahangir Dastgir Shaikh

Jahangir Dastgir Shaikh currently holds 1 directorship: Absien Pharmaceuticals Private Limited (Director, since 28 Feb 2024).

Jahangir Dastgir Shaikh was first appointed on 28 Feb 2024 as Director at Absien Pharmaceuticals Private Limited.

The current boards of Jahangir Dastgir Shaikh's companies include Amar Maulasab Shaikh (Absien Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available